169 related articles for article (PubMed ID: 7699466)
1. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease.
Hashikawa K; Matsumoto M; Moriwaki H; Oku N; Okazaki Y; Seike Y; Uehara T; Tanabe H; Ohie Y; Kamada T
J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
3. Use of neural networks in brain SPECT to diagnose Alzheimer's disease.
Page MP; Howard RJ; O'Brien JT; Buxton-Thomas MS; Pickering AD
J Nucl Med; 1996 Feb; 37(2):195-200. PubMed ID: 8667044
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.
Perani D; Di Piero V; Vallar G; Cappa S; Messa C; Bottini G; Berti A; Passafiume D; Scarlato G; Gerundini P
J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784
[TBL] [Abstract][Full Text] [Related]
5. Interactive three-dimensional region of interest analysis of HMPAO SPECT brain studies.
Hooper HR; McEwan AJ; Lentle BC; Kotchon TL; Hooper PM
J Nucl Med; 1990 Dec; 31(12):2046-51. PubMed ID: 2266407
[TBL] [Abstract][Full Text] [Related]
6. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
7. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy.
Zubal IG; Spencer SS; Imam K; Seibyl J; Smith EO; Wisniewski G; Hoffer PB
J Nucl Med; 1995 Apr; 36(4):684-9. PubMed ID: 7699465
[TBL] [Abstract][Full Text] [Related]
8. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
[TBL] [Abstract][Full Text] [Related]
9. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.
Karbe H; Kertesz A; Davis J; Kemp BJ; Prato FS; Nicholson RL
Neuroradiology; 1994; 36(1):1-6. PubMed ID: 8107986
[TBL] [Abstract][Full Text] [Related]
10. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
[TBL] [Abstract][Full Text] [Related]
13. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain.
Holman BL; Zimmerman RE; Johnson KA; Carvalho PA; Schwartz RB; Loeffler JS; Alexander E; Pelizzari CA; Chen GT
J Nucl Med; 1991 Aug; 32(8):1478-84. PubMed ID: 1869966
[TBL] [Abstract][Full Text] [Related]
14. A method of two-dimensional mapping of cortical perfusion by cylindrical transformation of HMPAO SPET data.
Ichise M; Crisp S; Ganguli N; Tsai S; Gray BG
Nucl Med Commun; 1995 May; 16(5):386-94. PubMed ID: 7659391
[TBL] [Abstract][Full Text] [Related]
15. Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography.
Dougall N; Nobili F; Ebmeier KP
Psychiatry Res; 2004 Jul; 131(2):157-68. PubMed ID: 15313522
[TBL] [Abstract][Full Text] [Related]
16. A new method for brain functional study using Tc-99m HMPAO SPECT.
Momose T; Kosaka N; Nishikawa J; Ohtake T; Watanabe T; Iio M
Radiat Med; 1989; 7(2):82-7. PubMed ID: 2798934
[TBL] [Abstract][Full Text] [Related]
17. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
Holman BL; Johnson KA; Gerada B; Carvalho PA; Satlin A
J Nucl Med; 1992 Feb; 33(2):181-5. PubMed ID: 1732438
[TBL] [Abstract][Full Text] [Related]
18. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
[TBL] [Abstract][Full Text] [Related]
20. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.
Liu RS; Lin KN; Wang SJ; Shan DE; Fuh JL; Yeh SH; Liu HC
Nucl Med Commun; 1992 Oct; 13(10):744-8. PubMed ID: 1491839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
